Medtronic Cardiovascular
medtronic.comTotal trials
69
Active
16
Phase 3
2
Total enrollment
26,058
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- Aortic Valve Stenosis10
- Aortic Aneurysm, Abdominal5
- Heart Valve Diseases4
- Aortic Aneurysm, Thoracic4
- Severe Aortic Stenosis4
- Thoracic Aortic Aneurysms3
- Abdominal Aortic Aneurysms3
- Symptomatic Aortic Stenosis3
Frequently asked questions about Medtronic Cardiovascular
- How many clinical trials does Medtronic Cardiovascular have on ClinicalTrials.gov?
- Medtronic Cardiovascular is listed as the lead sponsor on 69 clinical trials in ClinicalTrials.gov, 16 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Medtronic Cardiovascular's trials are in Phase 3?
- 2 of Medtronic Cardiovascular's trials are in Phase 3.
- What therapeutic areas does Medtronic Cardiovascular focus on?
- Medtronic Cardiovascular's most-studied conditions on ClinicalTrials.gov are Aortic Valve Stenosis, Aortic Aneurysm, Abdominal, Heart Valve Diseases, Aortic Aneurysm, Thoracic, Severe Aortic Stenosis.